Publication | Open Access
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
201
Citations
22
References
2020
Year
ClinicalTrials.gov Identifier: NCT02672852.
| Year | Citations | |
|---|---|---|
Page 1
Page 1